PURPOSE This retrospective study we clarified the clinical, epidemiological , evolutionary and therapy caracteristics at this leukoderma and then make a comparison with literature ;
 
METHODS: This is a retrospective study of 1010 patients who were followed in our clinic during the period from 2007 to 2011.
 

RESULTS: 1010 patients were collected:

  • 516women: 51.1%
  • 494men: 48.9%
  • sex ratio: F / H = 1.044

The average age is 31.4 years;
the age range of 1.5 to 80 years;
the peak incidence is in the third decade of life;
family interference was noted in 31.1% of cases.
                        *
 LOCATION OF INJURY:
The head: face, scalp, hair and flag of ears are achieved in 59.4% of cases;
the trunk is achieved in 44.3% of cases;
members are achieved in 81.4% of cases;
genitals are achieved in 28.7% of cases.
                     
  *TREATMENT:
The vast majority of patients were subjected to a low-dose corticosteroids: 97% of cases.
The majority of patients were treated with our preparation in the form of solution used during the day with; or without
 light exposure to sun or  lamp UVA  (see details in our website http://www.vitiligo.tn) : 83.7% of cases.
 
66.1% of patients were treated with our preparation in the form of cream used in the evening.
                      
 *EVOLUTION:
The result after treatment is clearly favorable: (decrease in size, partial repigmentation, total repigmentation of the lesions) in 77.8% of cases.
Minimal improvement was noted in 15.2% of patients (mild dimunition of achromia).
A poor outcome (worsening of the lesions from the beginning of treatment) was noted in 5,2% of cases.The result is in most cases recovered after adjustement of treatment.
Stabilization of the lesions was evident in 1.8% of cases.
Relapse and / or recurrence and / or new lesions were noted in 28.1% of cases.
 
 IN CONCLUSION:
 
our statistical results are relatively different from literature data.The causes of this difference and the valuable benefits of our experience are described in detail in the section "News".